Lumenis Ltd., is holding an educational symposium at this year’s COSM event, entitled “Challenging Cases Helped by Dual CO2 Laser Modalities.”
Israeli medical technology company Lumenis Ltd., is the world’s largest energy-based medical company for surgical, ophthalmology, and aesthetic applications. The company has recently announced close to double digit revenue growth with recently introduced products contributing towards 18% of all product revenues.
Lumenis says its AcuPulse DUO is the only integrated CO2 laser system to offer seamless adjustment between the two therapeutic modalities. The DUO platform is accompanied by a wide range of surgical tools, along with cost effective fibers, featuring renewable tips, aiming beam and high energy transmission. The DUO CO2 laser system is designed for smart tissue management and for optimal treatment of hard-to-reach anatomy.
The Combined Otolaryngology Spring Meetings (COSM) 2015, being held in Boston, Mass., from April 22 – 26, 2015.
Marc Remacle, M.D., Ph.D., Department of ORL and Head & Neck Surgery, University Hospital of Mont-Godinne, Belgium, and moderator of the Lumenis symposium, commented: “Providing precise, individualized patient care can be challenging for ENT surgeons because of the broad spectrum of surgical situations that can arise during the procedure. With the combined modality of the CO2 laser and the easy shift between free beam and fiber deliveries I can delicately address any clinical challenge while preserving healthy tissue, which is very important for the patient’s recovery and comfort.”
“Precision is a critical factor for attaining zero tumor margins,” said Joshua Schindler, M.D., Associate Professor and Medical Director, Northwest Center for Voice and Swallowing, Oregon Health & Science University. “Seeing the margin and surgical plane can be achieved by the unique capabilities of the fiber, which enables to complete surgical procedures, leaving no disease behind.”
“The DUO technology represents an important breakthrough in CO2 laser surgery for ear, nose and throat conditions,” said Tzipi Ozer-Armon, CEO of Lumenis. “More head and neck surgeons are recognizing the importance of having both free beam and fiber delivery options ready for challenging clinical cases, and our goal is to preserve the innovative approach and bring to market future advances in the field.”
Source: Globe Newswire